The aim was to identify and evaluate existing patient-reported outcome measures (PROMs) for use in patients with an abdominal aortic aneurysm (AAA) to inform the selection for use in surgical practice.
Introduction
Abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta. Recent statistics from a UK screening programme suggest a prevalence of 1⋅3 per cent for 65-year-old men 1 . Most AAAs are asymptomatic, but rupture is usually fatal 2 . In 2010, the UK National Health Service (NHS) introduced a National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in England for all men aged 65 years as a way of improving mortality rates in this population by monitoring and surgical intervention. Despite an expected increase in elective repairs owing to the introduction of screening, recent evidence from the National Vascular Registry 3 suggests that the number of repairs is stable or reducing slightly. It is generally recommended that AAAs larger than 5⋅5 cm on ultrasound imaging be considered for surgical repair. Early detection combined with advances in surgical techniques such as endovascular repair (EVAR) have improved morbidity and mortality rates 4 , although there remains debate about the effect on long-term outcomes.
Patient-reported outcome measures (PROMs) are questionnaires designed to provide a means of measuring health or quality of life (QoL) from the patient's perspective. They enable postsurgical outcomes wider than the traditional measures of outcome such as mortality or morbidity to be recorded 5 . They can capture changes to health status and QoL throughout the process of care, and allow information to be recorded on the impact of different surgical techniques to help inform treatment decisions 6 . The use of PROMs is becoming more widespread. Since 2009 the NHS has made it a requirement to collect PROM data from patients before and after surgery in four surgical conditions: hip replacement, knee replacement, varicose vein treatment and groin hernia repair.
PROMs can be categorized as generic or condition-specific. Both of these may also have utility (preference) values estimated for the responses and therefore become preference-based measures. Generic PROMs allow comparisons to be made across patient groups and, if preference-based, can be used to estimate preference weights for calculating quality-adjusted life-years, from which the economic value of interventions can be assessed. However, generic PROMs do not always measure the specific symptoms and health impact of individual conditions appropriately. Condition-specific PROMs allow greater detail to be collected on a patient disease group and therefore can be more useful in a clinical setting. It is generally recommended to use both a generic and a condition-specific PROM for measuring patient outcomes 7 .
There are many PROMs available and it is important to use those that have followed best practice in terms of their development and evaluation. The guidance on PROM development issued by the US Food and Drug Administration (FDA) 8 recommends that the items and domains covered by a PROM are developed through qualitative studies and are 'appropriate and comprehensive relative to its intended measurement concept, population, and use' 8 .
The aim of the present study was to synthesize and critically appraise the properties of PROMs available for patients with an AAA, to aid recommendations for their use in surgical practice. These reviews form part of a larger study funded by the National Institute for Health Research (NIHR) concerned with selecting PROMs for use in vascular services. The specific objectives were: to conduct a systematic review of the literature to identify and appraise the psychometric properties of validated PROMs for AAA; to carry out a qualitative evidence synthesis of the qualitative literature to identify health and QoL themes reported by patients; and to triangulate the identified PROM items with the qualitative review themes.
Methods
Two reviews were conducted; the first was a systematic review of PROMs validated in patients with an AAA, and the second a qualitative evidence synthesis to identify health and QoL outcomes from patients.
Systematic review of abdominal aortic aneurysm patient-reported outcome measures
The systematic review was reported in accordance with PRISMA recommendations 9 . The study protocol is available at https://www.shef.ac.uk/scharr/sections/heds/ discussion-papers/16-04-1.550120.
Searches
Systematic searches were undertaken in eight electronic databases and research registers (including MEDLINE and the Cochrane Library), using a two-stage approach. Stage 1 combined terms for known generic and condition-specific PROMs and terms for AAA. In stage 2, these terms were added to the preliminary search strategy and combined with a methodological search filter for finding studies on measurement properties 10 . Databases were searched from inception to September 2014 (stage 1) and to November 2014 (stage 2). No language or date restrictions were applied. Searches were supplemented by hand-searching reference lists of relevant reviews and included studies, and contact with experts in the field. Further details of the search strategies are provided in Appendix S1 (supporting information).
Study selection
All titles were examined and any citations that clearly did not meet the inclusion criteria (for example non-human, unrelated to AAA) were excluded. All abstracts and full-text articles were then reviewed by at least two individuals. Any disagreements in the selection process were resolved by discussion, with involvement of a third reviewer when necessary. Eligible studies included published articles in English of any study design that reported the psychometric properties of PROMs capturing QoL, health status or functional limitation in patients with an AAA. Psychometric properties included: validity (the degree to which the instrument measures what it is supposed to measure); reliability (the degree to which measures are reproducible and consistent over time in patients with a stable condition); responsiveness (the degree to which the instrument detects meaningful change over time if a change truly exists); and acceptability (the degree to which the instrument is acceptable to the patients). Studies reporting only outcomes of treatment satisfaction were excluded. The population of interest was patients with a diagnosis of AAA undergoing surveillance or any treatment, regardless of clinical presentation, diagnostic criterion or underlying cause. Studies published in English that reported non-English translations of relevant PROM instruments or PROMs elicited from non-English speakers were excluded. This was considered a suitable approach to overcome the uncertainty due to language validation and cross-cultural adaptation of PROMs 11 .
Data abstraction
Data relating to study design, patient characteristics, type of PROM, methods and outcomes were extracted by one reviewer into a standard data extraction form, and checked independently for accuracy by a second reviewer. Any discrepancies were resolved by discussion with a third reviewer. Where necessary, study authors were contacted for missing information or additional data.
Psychometric evaluation and methodological quality assessment of patient-reported outcome measures
The psychometric properties and methodological quality of each PROM were appraised by two researchers. Disagreements in the ratings were discussed and agreed by a third researcher. PROMs were classified according to whether they were generic preference-based or condition-specific preference-based.
Owing to lack of consensus on how to appraise PROMs, study-specific criteria adapted from published recommendations were used to evaluate the psychometric performance of identified validated PROMs 8,12 -16 . The developed criteria were also consistent with FDA guidance 8 and are outlined in Table 1 13 -17 .
Qualitative evidence synthesis

Qualitative searches
In accordance with the study protocol (see https://www .shef.ac.uk/polopoly_fs/1.550136!/file/Patient_reported_ outcome_measures_in_patients_with_abdominal_aortic_ aneurysms.pdf), searches were conducted in bibliographic databases (including MEDLINE and CINAHL) in April 2015. The search was based on the search strategy created for the related review of PROMs for AAA. The search strategy combined condition terms, terms for PROMs/patient views and terms for qualitative studies (which augmented a qualitative study filter) 18 . Further details of the search strategies are provided in Appendix S1 (supporting information).
Qualitative study selection
Two reviewers read the titles and abstracts for the inclusion and exclusion criteria. For abstracts that appeared to meet A good argument should be made as to why an instrument is a standard, and correlation with the standard should be ≥ 0⋅70 16 
Responsiveness
There are a number of methods to measure this including t tests, effect size, standardized response means or responsiveness statistics, such as Guyatt's responsiveness index. There should be statistically significant changes in score of an expected magnitude 17 Floor/ceiling effects A floor or ceiling effect is considered if 15% of respondents are achieving the lowest or the highest score on the instrument 16 
Acceptability
Acceptability is measured by the completeness of the data supplied; ≥ 80% of the data should be complete 14 the inclusion criteria, full-text articles were obtained for more detailed information. All titles were examined, and any citations that clearly did not meet the inclusion criteria (for example non-human, unrelated to AAA) were excluded. Eligible studies included published articles in English of primary qualitative studies (such as focus groups and interviews) that explored the experiences, health or QoL of patients with AAA (any patient with a diagnosis of AAA undergoing surveillance or any treatment, regardless of clinical presentation, diagnostic criterion or underlying cause). Studies that did not report qualitative themes in their results were excluded. Owing to the paucity of qualitative research studies identified in the initial searches, a decision was made to include studies conducted in a non-English-speaking population, on the basis that they would provide insight into the impact of AAA.
Qualitative data extraction and analysis
Data were extracted and tabulated on authors, date of publication, country of study, number of participants, research aims, method of recruitment, method of data collection, key results and analysis. The results and discussion sections of each article, including primary and secondary text (patient quotes reported in the articles and themes), were coded. The text of each article was analysed using framework analysis 19 to identify themes from within and across the articles. The researcher went through each section coding to identify initial themes. Text from each of the included studies was collated into themes and charted by study to create a framework matrix. Themes were examined for their conceptual similarities and differences. The themes that arose were then checked by a second reviewer with extensive experience of qualitative reviewing, and differences in conceptualization were discussed and adjusted. The Critical Appraisal Skills Programme (CASP) qualitative research checklist 20 was used to assess the methodological quality of the included studies. CASP consists of ten questions about the qualitative methodology that are answered either as yes, no or unclear.
Triangulation of patient-reported outcome measure items with qualitative themes
Items from the identified PROMs were mapped against the themes from the qualitative synthesis to explore whether the PROM items captured the themes important to patients. A triangulation approach 21, 22 was followed, whereby the researcher examined the themes from both the qualitative review and the PROM items/domains to evaluate whether the concepts were the same (agreement), offered similar concepts (partial agreement), appeared to contradict each other (dissonance) or were not present (silence). The FDA 8 recommends that both a generic and condition-specific measure are used when collecting patient outcomes. Therefore, it was important to examine the extent to which the items within the generic measures corresponded or overlapped with those from the condition-specific measures.
Results
Systematic review of patient-reported outcome measures
A total of 1232 records were identified, of which 65 full-text articles were considered potentially eligible for inclusion (including an abstract 23 that reported two measures (Aneurysm Symptom Rating Questionnaire (AneurysmSRQ) and Aneurysm-Dependent Quality of Life (AneurysmDQoL)) which has subsequently been published 24, 25 ). Following detailed screening, three studies (reporting on 4 PROMs) 24 -27 were finally included in this review. All the included studies reported the validation of PROMs in patients with an AAA. The majority of the excluded articles did not clearly report outcomes or present data evaluating the measurement properties of PROMs. The Aneurysm Treatment Satisfaction Questionnaire (AneurysmTSQ) was excluded as this was a patient satisfaction questionnaire, not an outcomes assessment 24, 25 . A summary of the process of identifying and selecting the relevant literature is presented in Fig. 1 .
Study characteristics
The three included studies were all prospective, and undertaken in the UK 24, 25 , Australia 26 and the USA 27 . Two of the studies 24 -26 reported details of designing and piloting the PROMs, whereas one 27 reported only details of using a PROM in patients undergoing AAA surgery ( Table 2) .
Overall, the studies were of a small to moderate size with the number of patients ranging from 95 27 to 191 24 . The proportion of men in the study samples ranged between 82 per cent 26, 27 and 90⋅1 per cent 24 , and the mean age ranged from 72 years 27 to 75 years 24, 26 .
The patients' clinical diagnosis varied across studies. Both Mangione et al. 27 and Borchard et al. 26 included patients with co-morbidities; however, in the former study 27 it was unclear what these were. Peach et al. 24 did not report any data related to patient co-morbidities. Mangione et al. 27 included patients undergoing AAA surgery, and those who were evaluated before and after elective surgery. Peach et al. 24 included patients who had undergone AAA repair (using open or endovascular techniques), or were under preoperative surveillance with an aneurysm that was below the threshold size for intervention. Borchard et al. 26 included patients who had undergone AAA repair (both open and endovascular).
Data, psychometric evaluation and methodological assessment
In total, four PROMs were identified where psychometric evaluation had been completed in patients with AAA. Citations screened by title after removal of duplicates n = 1201
Full-text articles assessed for eligibility n = 65
Studies included in synthesis n = 3
Citations screened by abstract n = 268
Citations identified through database searching n = 315
Titles and abstracts screened for inclusion after removal of duplicates n = 230
Citations excluded by title and abstract n = 202
Full-text studies assessed for eligibility n = 28
Studies excluded after review of full text n = 25
Studies included in synthesis n = 4
Studies meeting qualitative review inclusion criteria n = 1
Articles excluded after review of full text n = 62
Citations excluded by title n = 933
Citations excluded by abstract n = 203 evidence of internal consistency and construct validity in the patients with AAA 27 . The correlation coefficient was 0⋅4 between the 0-100 rating scale and the mental health scale of the SF-36 ® ; correlations with other domains were lower but statistically significant. Responsiveness assessed using a relative efficiency statistic ranged from 1⋅1 to 6⋅7 in the combined construct, showing high responsiveness; tests were statistically significant.
The AUSVIQUOL was developed by Borchard et al. 26 to measure the QoL of patients with vascular disease and of those with an AAA in a clinical setting. The items and domains of AUSVIQUOL were determined by examination of a prospective database for frequency of symptoms and an in-depth interview of a random sample of patients with an AAA. The AUSVIQUOL has three main domains relating to perception of general health: functional, mobility and pain, and psychosocial aspects. The AUSVIQUOL was developed with patients and has excellent content validity 26 , which was rated good according to the established psychometric criteria. The construct validity of the tool was tested by comparing it with SF-36 ® in 60 patients who underwent EVAR and 48 patients who underwent open AAA repair using factor analysis and regression analysis. As no correlation coefficients were reported, construct validity could not be rated. To compare the reliability of the two tools, 22 patients were reassessed using SF-36 ® and AUSVIQUOL. Given the small sample, the test-retest reliability was rated poor. Although acceptability could not be rated according to the agreed criteria, this study found that the majority of participants had difficulty completing it, suggesting low acceptability. The AneurysmDQoL and the AneurysmSRQ were developed and validated by Peach et al. 24, 25 . They used semistructured interview techniques to explore patients' experience of having an AAA in a series of focus groups and in-depth interviews. The information gathered was used to inform design and selection of items for the new tools. The AneurysmDQoL consists of 24 items; there are 22 domains specific to patients with an AAA, and a further two additional items to assess overall QoL and the impact of AAA on QoL. The AneurysmSRQ is a 44-item, aneurysm-specific measure, which assesses a wide range of physical and psychological symptoms reported by patients with an AAA, with two free-text questions. The tools were further completed by 191 patients from the NHS Trusts for psychometric validation assessment. The initial validation of the tools reported the trend scores of the different instruments but did not report psychometric properties of the measures. However, the tools show good content validity according to standard psychometric appraisal criteria 24 . 
Qualitative evidence synthesis
Some 315 citations were identified through the database searches; on sifting, 85 duplicates were excluded, leaving 230 studies (Fig. 1) . The 230 titles and abstracts were assessed, and 202 citations were subsequently excluded from the review. The remaining 28 full-text papers were screened against the eligibility criteria and 25 were excluded, leaving only three studies that met the inclusion and exclusion criteria. Through the quantitative review an abstract for the development of a new condition-specific PROM for AAA was identified 23 . On contacting the authors, they agreed to share the methods paper for the PROM development, which was subsequently published 24, 25 . This has been included in both reviews; four studies were therefore included in the qualitative synthesis.
Characteristics and main findings of the studies included in the qualitative synthesis are summarized in Table 3 . Three 30 -32 of the four included studies were conducted in Sweden in Swedish, although the texts of the articles were published in English. Two 30, 32 of the four studies carried out semistructured interviews with patients with an AAA identified by screening and being treated conservatively, one 31 focused on patients who received open surgery for the AAA, and the final study 24, 25 presented a mix of patients including those being treated either conservatively, or with open repair or EVAR.
Quality assessment
Against the CASP checklist 20 it was found that all studies met 'yes' on almost all items, showing evidence of being good quality. The item on whether the researcher had adequately considered their relationship with participants was graded as 'can't tell' for two studies 30, 31 .
Triangulation of review data
Four overarching themes were identified from the four studies included in the qualitative synthesis: symptoms, functional outcomes, psychological outcomes and social outcomes ( Table 4) . A summary of the quotes is provided in Table S3 (supporting information) .
Symptoms
This theme included 13 health-related concepts from the included studies. These were: feeling no −/+ − /+ + Gastrointestinal upset 24, 25, 31, 32 . . + Numbness 24, 25, 31 . . + Swelling 24, 25, 31 . . + Bruising 24, 25 . . + Weakness 24, 25, 31 . . + Heaviness 24, 25 . . 24, 25, 31 . + + Weight loss 24, 25, 31 . . + Appetite 24, 25, 31 . . + Co-morbidities 30 . .
−/+ Psychological outcomes
Concern over bodily symptoms 24, 25, 31, 32 . . + Concern over changes in size of the aneurysm 32 . . . Age-related health expectations 32 + + + Ability to forget about the condition 31, 32 . . . Cognitive function 24, 25 −/+ . + Anxiety 30 -32 . . + Depression, fatalism, helplessness 32 . 30 . . + Lifting heavy objects 24, 25, 31, 32 . + −/+ Ability to travel 24, 25, 31, 32 . . + Financial implications 25 . physical symptoms 24, 25, 30, 32 ; pain 24, 25, 30 ; gastrointestinal upset 24, 25, 31, 32 ; numbness, swelling, bruising, weakness and heaviness 24, 25, 31 ; sleep 31 ; fatigue 24, 25, 31 ; weight loss 24, 25, 31 ; appetite 24, 25, 31 ; and co-morbidities 30 . All items except co-morbidities and changes in size of the aneurysm were covered by the AneurysmSRQ. The SF-36 ® was rated as having partial agreement with the pain theme and agreement with a question on fatigue/lethargy. The AUSVIQUOL also asked about pain and sleep but this was combined with another question and therefore was rated as only meeting partial agreement.
Functional outcomes
Functional items were those related to everyday activities or physical functioning, including the effect on day-to-day life 24, 25, 31 , sexual function 30 , lifting heavy objects 24, 25, 31, 32 , ability to travel 24, 25, 31, 32 and financial implications 25 . The AneurysmDQoL and the AneurysmSRQ had items that covered all of the identified themes classified under functional outcomes. The AUSVIQUOL and SF-36 ® both included an item on everyday functioning. The SF-36 ® included an item on the ability to lift heavy objects.
Psychological outcomes
Concepts included concern over bodily symptoms and changes in the size of the aneurysm, age-related health perceptions, ability to forget about the condition, cognitive function, anxiety, depression, fear of rupture and control 24,25,30 -32 . Fear of rupture, control 24,25,30 -32 , concern about changes in the size of the aneurysm 32 and ability to forget about the condition 31, 32 were all themes covered in the qualitative studies, but silent in the identified PROM items. The AneurysmDQoL and AneurysmSRQ did not have items on concern over aneurysm, ability to forget about the condition, fear of rupture and death, or control. The SF-36 ® included items on depression and age-related health perceptions, for which agreement was shown. The AUSVIQUOL was rated as having agreement for age-related health perceptions, and partial agreement with cognitive function.
Social outcomes
Two studies 24, 25, 32 detailed the effects of AAA on families and that this worsened the patient's own concerns. Patients expressed that their families were worried and concerned about the threat the aneurysm posed to the patient and thereby also to the family circumstances 32 . This is in agreement with items on the SF-36 ® and the AneurysmDQoL.
Discussion
This study provides a review of the psychometric properties of PROMs for AAA and of the qualitative literature on patients' experiences of having an AAA. The aim of the review was to synthesize and critically appraise PROMs psychometrically evaluated in an AAA population to make recommendations for their use in surgical practice. The systematic review identified four PROMs (from 3 studies) 24 -27 that had undergone psychometric testing for use in patients with an AAA. None of the identified PROMs had undergone full rigorous psychometric testing. The SF-36 ® showed good evidence of internal consistency, construct validity and responsiveness, but did show some floor or ceiling effects; one of the studies 26 reported that older patients found some of the items irrelevant, suggesting low acceptability. The AUSVIQUOL, a generic vascular measure, showed good content validity according to the criteria as it had been developed by interviewing patients with an AAA as well as other conditions, although the qualitative review paper 33 is not included here as it combines the results of all conditions and was thus excluded. The responsiveness and internal consistency of the AUSVIQUOL had not been assessed. The AneurysmDQoL and AneurysmSRQ are both condition-specific measures of health and QoL, and have comparable trend scores, but a conventional psychometric evaluation has not yet been performed. They were developed from the most comprehensive qualitative study of experiences of patients with an AAA, including those receiving conservative treatment, open repair or EVAR. Details of the process of tool development were reported by both Borchard et al. 26 and Peach et al. 24, 25 . Both studies had potential issues with respect to item identification and retention. The items for the AUSVIQUOL 26 were chosen on the basis of the frequency of reported symptoms from patients undergoing AAA repair, but it was unclear how these data were captured. Furthermore, validation of item inclusion and reduction was on the basis of ten semistructured interviews which were centred on the relevance of the items already identified, rather than checking the breadth and completeness of the identified domains. The item selection for the AneurysmDQoL 25 was based on focus groups of patients with an AAA and relied on recall of their treatment. Questions were constructed for the identified areas from existing questionnaires.
The qualitative synthesis identified only four studies 24, 25, 30 -32 reporting on patients' experiences of having an AAA. When the themes from these studies were mapped on to the items of the identified PROMs it was found that none of the current PROMs covered all of the concepts from the qualitative studies, although the AneurysmSRQ and AneurysmDQoL together covered 24 of the 28 identified concepts. Fear of rupture was not captured by any of the PROMs, despite being recorded as a key theme in all four of the qualitative studies. Similarly, difficulty in forgetting about the AAA was reported in two of the qualitative studies, but was not reflected in the PROMs. It could be that fear and ability to forget about the condition are associated with distress, and so measuring the more general theme of distress was thought to cover this concept. Given the frequency of patients reporting fear around AAA, further research is needed to explore this theme and whether it is covered adequately by the existing PROMs.
The main strength of this PROM systematic review was the comprehensive two-step search strategy used to identify studies. The review was undertaken by a multidisciplinary team of clinical and methodological experts according to recommended standards. However, a number of limitations to the review process should be noted. First, data extraction for the qualitative synthesis and triangulation protocol was applied by a single researcher. It is known that having two reviewers conducting each stage of a review reduces the incidence of error 34, 35 . The process and emerging themes were discussed with an experienced qualitative reviewer.
Three 30 -32 of the four studies included in the qualitative synthesis (review 2) had been conducted in Sweden. The systematic review excluded PROMs not developed in an English-speaking population, whereas the qualitative synthesis included them, albeit they were published in English. Only one of the qualitative studies 25 was conducted in English, highlighting the paucity of published research exploring patients' qualitative experiences of the condition.
Macefield et al. 6 wrote about the difficulties in comparing concept PROMs. Items within the AUSVIQUOL lacked clarity over the conceptual domain they were intended to measure, making data synthesis with the SF-36 ® difficult.
For example, when asking whether pain disturbs sleep, in the same question they ask whether pain distorts mobility: 'do you have pain or discomfort in your legs or feet that limits your mobility or disturbs your sleep, ulcers on your feet or have you lost a limb?'. It is also unclear whether the questionnaire would relate to those who have been identified with an AAA who do require or have not undergone surgery.
The samples in the studies included in the reviews were heterogeneous, including patients at different stages of treatment. Of the four identified studies, only two 24, 25, 31 included patients after treatment. There needs to be further exploration of patients after treatment. Peach et al. 24, 25 provide the most extensive qualitative study, including patients at each stage of treatment.
Despite recent publications on outcomes for patients with an AAA, as yet there would seem to be a paucity of qualitative research in this area, with only one UK study 24, 25 cited. In recommending a PROM to measure outcomes after surgery it is important to include measures that both capture the breadth of the patient experience and provide instruments that are reliable, valid and acceptable to patients. Research exploring how to integrate PROMs into the patient pathway is needed. If PROMs are to be integrated into practice, it would be useful to administer them at different stages of each patient's care over at least two time points.
